Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Anbisheng Pharmaceutical Technology is a specialized pharmaceutical company based in Shanghai, China, focused on the development and commercialization of high-end generic drugs and complex formulations. Founded in 2007 by industry experts with extensive experience in multinational corporations, the company emphasizes quality standards that meet both NMPA and US FDA requirements. Anbisheng operates a robust technology platform for drug delivery systems, including sustained-release and controlled-release oral solids. The company has successfully obtained multiple ANDA approvals for products targeting central nervous system disorders, infectious diseases, and cardiovascular conditions. In addition to its internal pipeline, Anbisheng provides CRO and CDMO services to global partners, leveraging its expertise in formulation science and regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Anbisheng Pharmaceutical Technology.